Correlation Between Conduit Pharmaceuticals and Repligen
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Repligen, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Repligen.
Diversification Opportunities for Conduit Pharmaceuticals and Repligen
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Conduit and Repligen is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Repligen go up and down completely randomly.
Pair Corralation between Conduit Pharmaceuticals and Repligen
Considering the 90-day investment horizon Conduit Pharmaceuticals is expected to under-perform the Repligen. In addition to that, Conduit Pharmaceuticals is 3.26 times more volatile than Repligen. It trades about -0.19 of its total potential returns per unit of risk. Repligen is currently generating about 0.16 per unit of volatility. If you would invest 11,480 in Repligen on July 20, 2025 and sell it today you would earn a total of 3,780 from holding Repligen or generate 32.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Conduit Pharmaceuticals vs. Repligen
Performance |
| Timeline |
| Conduit Pharmaceuticals |
| Repligen |
Conduit Pharmaceuticals and Repligen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Conduit Pharmaceuticals and Repligen
The main advantage of trading using opposite Conduit Pharmaceuticals and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.| Conduit Pharmaceuticals vs. Zivo Bioscience | Conduit Pharmaceuticals vs. Aditxt Inc | Conduit Pharmaceuticals vs. Aspire BioPharma, | Conduit Pharmaceuticals vs. ZyVersa Therapeutics |
| Repligen vs. Intuitive Surgical | Repligen vs. ResMed Inc | Repligen vs. Merit Medical Systems | Repligen vs. ICU Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |